跳至主要内容
临床试验/ACTRN12610000914066
ACTRN12610000914066招募中不适用

Comparison of refractive performance of implantation of an iris-fixated phakic intraocular lens (PIOL) through a novel trapezoidal corneal and a scleral tunnel incision.

Beijing Tongren Hospital, Capital Medical University0 个研究点目标入组 35 人开始时间: 2010年10月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • (1) anterior chamber depth (ACD) of 3.0 mm or greater with regular iris configuration; (2) preoperative endothelial cell count of 2000 cells/mm2 or greater; (3) preoperative spherical equivalent (SE) greater than -15.0 D, with astigmatism less than 2.0 D; (4) stable refraction, defined as less than 0.5 D change for more than 1 year; (5) no other ocular and systemic diseases.

排除标准

  • (1) abnormal iris, cornea, pupil, or retina; (2) acute inflammation; (3) any form of cataract; (4) glaucoma; (5) chronic or recurrent uveitis; (6) preexisting macular degeneration, retinopathy, or family history of retinal detachment; (7) intraocular pressure (IOP) higher than 21mm Hg; (8) chronic treatment with corticosteroids or any immunosuppressive treatment or state.

研究者

发起方
Beijing Tongren Hospital, Capital Medical University

相似试验